Tsuneo Namba

7.5k total citations
207 papers, 6.4k citations indexed

About

Tsuneo Namba is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Tsuneo Namba has authored 207 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 79 papers in Plant Science and 59 papers in Pharmacology. Recurrent topics in Tsuneo Namba's work include Phytochemistry and Biological Activities (46 papers), Natural product bioactivities and synthesis (39 papers) and Pharmacological Effects of Natural Compounds (28 papers). Tsuneo Namba is often cited by papers focused on Phytochemistry and Biological Activities (46 papers), Natural product bioactivities and synthesis (39 papers) and Pharmacological Effects of Natural Compounds (28 papers). Tsuneo Namba collaborates with scholars based in Japan, China and Taiwan. Tsuneo Namba's co-authors include Masao Hattori, Shigetoshi Kadota, Kyoichi Kobashi, Yasuhiro Tezuka, Purusotam Basnet, Koji Hase, Teruaki Akao, Tohru Kikuchi, Cheng‐Hsiung Chang and Tatsuya Sakamoto and has published in prestigious journals such as Tetrahedron, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Tsuneo Namba

203 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsuneo Namba Japan 47 3.1k 2.5k 1.6k 991 736 207 6.4k
Brigitte Kopp Austria 36 3.0k 0.9× 2.1k 0.8× 1.1k 0.7× 915 0.9× 1.1k 1.5× 114 6.4k
Ryoji Kasai Japan 51 5.5k 1.7× 2.8k 1.1× 1.1k 0.7× 828 0.8× 1.0k 1.4× 229 7.8k
Chun‐Ching Lin Taiwan 56 3.5k 1.1× 2.3k 0.9× 1.8k 1.1× 1.4k 1.5× 957 1.3× 148 8.2k
KiHwan Bae South Korea 50 3.5k 1.1× 1.8k 0.7× 1.1k 0.7× 984 1.0× 629 0.9× 224 6.8k
Toshihiro Akihisa Japan 51 4.5k 1.4× 2.3k 0.9× 1.2k 0.7× 868 0.9× 984 1.3× 245 8.6k
Toshio Miyase Japan 49 4.8k 1.5× 3.3k 1.3× 916 0.6× 688 0.7× 1.0k 1.4× 236 8.2k
Sandra Apers Belgium 41 2.6k 0.8× 2.8k 1.1× 1.3k 0.8× 737 0.7× 1.4k 1.9× 200 6.9k
Ken Yasukawa Japan 44 2.7k 0.9× 1.6k 0.6× 984 0.6× 685 0.7× 716 1.0× 147 5.7k
Kun Ho Son South Korea 47 4.0k 1.3× 1.9k 0.7× 940 0.6× 1.3k 1.3× 724 1.0× 152 7.3k
Ramadasan Kuttan India 47 2.3k 0.7× 1.9k 0.7× 1.8k 1.1× 1.4k 1.4× 892 1.2× 136 8.0k

Countries citing papers authored by Tsuneo Namba

Since Specialization
Citations

This map shows the geographic impact of Tsuneo Namba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuneo Namba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuneo Namba more than expected).

Fields of papers citing papers by Tsuneo Namba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuneo Namba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuneo Namba. The network helps show where Tsuneo Namba may publish in the future.

Co-authorship network of co-authors of Tsuneo Namba

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuneo Namba. A scholar is included among the top collaborators of Tsuneo Namba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuneo Namba. Tsuneo Namba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Namba, Tsuneo, et al.. (2004). Pharmacognostical studies on Yinchenhao. 21(4). 187–198. 1 indexed citations
2.
Yokozawa, Takako, Erbo Dong, Hiroshi Kashiwagi, et al.. (1997). In Vitro and In Vivo studies on Anti-Lipid Peroxidation Effect of Extract from Luobuma Leaves. Natural medicines = 生薬學雜誌. 51(4). 325–330. 6 indexed citations
3.
Li, Xiaobo, et al.. (1997). Pharmacognostical studies on the Chinese crude drug 'Shengma' (Part II): 'Shengma' derived from genus Cimicifuga plants. Natural medicines = 生薬學雜誌. 51(2). 148–161. 2 indexed citations
4.
Hattori, Masao, et al.. (1996). Two New Coumarins from the Roots of Aegle marmelos. Journal of Chinese Pharmaceutical Sciences. 5(2). 68. 10 indexed citations
5.
Chen, Long, et al.. (1995). Processing of Nux Vomica. IV. : A Comparison of Cytotoxicity of Nine Alkaloids from Processed Seeds of Strychnos nux-vomica on Tumor Cell Lines. 49(1). 39–42. 7 indexed citations
6.
Namba, Tsuneo, et al.. (1995). Pharmacognostical Study on the Chinese"Qiang-huo(羌活)"On the Anatomical Characteristics of the Underground Parts of Notopterygium incisum and N.forbesii. 49(4). 409–417. 2 indexed citations
7.
Kusumoto, Ines Tomoco, et al.. (1993). A Comparative Study on the Inhibitory Effects of Flavonoids and Alkaloids on Reverse Transcriptases of Different Retroviruses. 47(3). 291–294. 1 indexed citations
8.
Huang, Xinli, Masao Hattori, & Tsuneo Namba. (1992). Effects of a Carthami Flos Extract and Its Constituents on the Beating Amplitude of Cultured Myocardial Cell Sheets. 46(3). 210–216. 3 indexed citations
9.
Kusumoto, Ines Tomoco, Masao Hattori, Yukinori Miyaichi, et al.. (1991). Effects of Flavonoids and Alkaloids on Reverse Transcriptase. 45(3). 240–254. 4 indexed citations
10.
Hattori, Masao, Yukio Kawata, Yue‐Zhong Shu, et al.. (1990). Transformation of aucubin to new pyridine monoterpene alkaloids, aucubinines A and B, by human intestinal bacteria. Phytotherapy Research. 4(2). 66–70. 24 indexed citations
11.
Komatsu, Katsuko, Masayuki Mikage, & Tsuneo Namba. (1990). Pharmacognostical Studies on the Chinese Crude Drug"Fu pen zi"(覆盆子)-6-On Botanical Origin of"Fu pen zi"from Korea-3-. 44(4). 255–264. 1 indexed citations
12.
Mikage, Masayuki, et al.. (1988). Pharmacognostical Studies on the Chinese Crude Drug"Da-huang"(大黄,Rhubarb)-2-Botanical Origin of Three Unoffical Da-huang. 42(4). 302–309.
13.
Hattori, Masao, et al.. (1988). Constituents of the Stems of Eucommia ulmoides OLIV.. 42(3). 247–248. 8 indexed citations
14.
Lin, Chun‐Ching, Jen‐Yin Chen, & Tsuneo Namba. (1987). Development of Natural Crude Drug Resources from Taiwan-5-Pharmacognostical Studies on Chinese Crude Drug"Peh-hue-juwa-chi-chhau"(白花蛇舌草)-1-. 41(3). 180–188. 5 indexed citations
15.
Hattori, Masao, et al.. (1986). Studies in Dental Caries Prevention by Traditional Medicines-9-Potent Antibacterial Action of Coumarin Derivatives from Licorice Roots against Streptococcus mutants. 40(4). 406–412. 8 indexed citations
16.
Namba, Tsuneo & Kenji Inagaki. (1984). Pharmacognostical Studies on the Chinese Crude Drugs Derived from Insects (VII) : On the Original Insects of Qicao (〓〓). 38(1). 118–126. 2 indexed citations
17.
Mikage, Masayuki & Tsuneo Namba. (1983). Pharmacognostical Studies on the Clematis Plants and Related Crude Drugs-3-On "Wei-ling-xian"(威霊仙) from Korean Peninsula. 37(4). 325–333.
18.
Mikage, Masayuki & Tsuneo Namba. (1983). Pharmacognostical Studies on the Clematis Plants and Related Crude Drugs-2-On the Botanical Origin of "Wei-ling-xian"(威霊仙) from Taiwan and Liang-guang.. 37(4). 317–324.
19.
Namba, Tsuneo, et al.. (1982). Studies on Dental Caries Prevention by Traditional Chinese Medicines. Part III. : In vitro Susceptibility of a Variety of Bacteria to Magnolol and Honokiol, the Components of Magnoliae Cortex. 36(3). 222–227. 3 indexed citations
20.
Namba, Tsuneo & Chun‐Ching Lin. (1981). Pharmacognostical Studies on the Crude Drugs of Orchidaceae from Taiwan-4-On "Chioh-hak"(石斛)-1-. 35(3). 221–232. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026